Cargando…
Cellular Therapies in Solid Organ Allotransplantation: Promise and Pitfalls
Donor specific transfusions have been the basis of tolerance inducing protocols since Peter Medawar showed that it was experimentally feasible in the 1950s. Though trials of cellular therapies have become increasingly common in solid organ transplantation, they have not become standard practice. Add...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435835/ https://www.ncbi.nlm.nih.gov/pubmed/34526991 http://dx.doi.org/10.3389/fimmu.2021.714723 |